a public good project by the
Synthesis
Company
of California

© 2026

Léa Payen | doi.page

0 works0 citations0 h-index

Léa Payen

Hospices Civils de Lyon(FR)Hôpital Lyon Sud(FR)

Publications by Year

Research Areas

Drug Transport and Resistance Mechanisms, Cancer Genomics and Diagnostics, Ovarian cancer diagnosis and treatment, Intraperitoneal and Appendiceal Malignancies, Cancer Immunotherapy and Biomarkers

Most-Cited Works

→ Calcium channel ITPR2 and mitochondria–ER contacts promote cellular senescence and aging(2021)176 cited
→ p58IPK-Mediated Attenuation of the Proapoptotic PERK-CHOP Pathway Allows Malignant Progression upon Low Glucose(2013)145 cited
→ Up‐regulation of multidrug resistance‐associated protein 2 (MRP2) expression in rat hepatocytes by dexamethasone(1999)101 cited
→ The sulphonylurea glibenclamide inhibits multidrug resistance protein (MRP1) activity in human lung cancer cells(2001)97 cited
→ Physiological, pharmacological and clinical features of the multidrug resistance protein 2(2005)91 cited
→ The drug efflux pump MRP2: Regulation of expression in physiopathological situations and by endogenous and exogenous compounds(2002)85 cited

→ Role of Carboxylate Residues Adjacent to the Conserved Core Walker B Motifs in the Catalytic Cycle of Multidrug Resistance Protein 1 (ABCC1)(2003)

78 cited

→ Lysyl oxidase family activity promotes resistance of pancreatic ductal adenocarcinoma to chemotherapy by limiting the intratumoral anticancer drug distribution(2016)73 cited

→ Overexpression of the multidrug resistance‐associated protein (MRP1) in human heavy metal‐selected tumor cells(1999)70 cited

→ Reactive Oxygen Species-Related Induction of Multidrug Resistance-Associated Protein 2 Expression in Primary Hepatocytes Exposed to Sulforaphane(2001)68 cited